{"success":true,"data":{"pressRelease":{"id":"35890","rtpr_id":"nGNX8XHPqK","ticker":"QGEN","exchange":"NYSE","all_tickers":["QGEN","QIA"],"title":"QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations","author":"Globe Newswire","published_at":"2026-05-14T23:00:00.123Z","article_body":"NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney\nLLP\n(https://www.globenewswire.com/Tracker?data=HpuFE8BDbUz5zHzVeTW4CcH9x9umeHwWneV2jzy7mBcJWyVsPfHPvEExCuwY55bHrPkqt4RN_bad4-99HF2VxQJBLeUNlIMYzOR4b1g7nPI=)\nreminds investors of its investigation on behalf of Qiagen N.V. (“Qiagen”\nor the “Company”) (NYSE:QGEN) investors concerning the Company’s and/or\nmembers of its senior management’s possible violation of the federal\nsecurities laws or other unlawful business practices.\n\n[LEARN MORE ABOUT THE INVESTIGATION\n(https://www.globenewswire.com/Tracker?data=nJoh9sk07MJCBCfBtRnd3smwFo2iTg1_nMWy4D03z-E0qrGkJtbvDzIvpMVSHuneKVcZbyiULA3yXoyDjgvsfXFzRzacsn0oTjayTkPilBkWw0FIG84Miamtmjm-lRtmsSeyMwKmCC-FZRzEbk_zUopC737dnNzgdHNKKXaRlbA=)]\n\nWhat Happened?\n\nOn February 5, 2026, Qiagen released fourth quarter 2025 earnings and stated\nthat QuantiFERON would accelerate to achieve “between 6% and 7% growth” in\n2026.\n\nOn April 27, 2026, Qiagen announced preliminary results for the first quarter\nof 2026. Among other things, the Company disclosed that net sales declined\napproximately 1% on a constant exchange rate (“CER”) basis, and that sales\nof its QuantiFERON product declined approximately 5% CER. On this news, the\nprice of Qiagen shares declined by $4.07 per share, or approximately 11%, from\n$38.09 per share on April 27, 2026 to close at $34.02 on April 28, 2026.\n\nWhat Should I Do?\n\nAt this stage, no lawsuit has been filed. The investigation is ongoing to\ndetermine whether claims may be brought under federal securities laws.\n\nIf you purchased or otherwise acquired Qiagen securities, have information, or\nwould like to learn more about this investigation, please contact Lauren\nMolinaro\n(https://www.globenewswire.com/Tracker?data=RlDYPtLpel5m6m8EFtiv4BxO8wlQaSE2m_qHJAip4sVhbDSMWEzDYzPlndLxA9ULnLrlW-qF-0lC0E2ctcaElR0uNyThKAR28tX4t0syC7piWxo6mTCYNZvgo33Ilv5T)\nof Kirby McInerney LLP\n(https://www.globenewswire.com/Tracker?data=HpuFE8BDbUz5zHzVeTW4CZQlsOj4vEjSKg5Q9GKWnqUn7Ea3a3otTxeXJlii64DmO7HQ2YlFyV9ug3n4MZvd9G0GIQ2v3breHmal_Am7Dn0=)\nby email at investigations@kmllp.com, or fill out the contact form below, to\ndiscuss your rights or interests with respect to these matters at no cost.\n\n[LEARN MORE ABOUT SECURITES CLASS ACTIONS]\n(https://www.globenewswire.com/Tracker?data=iloA-mDV8wumtkDot69BfWrtrnRefb3ywsBuuK1QBi0lsTCguaDFCZwdCOS3afPgOTxVuE_KFzIFsFq92y9H0fbzj_opVSHEH1ji2pk0_hkD0UQGo97RHFheFeG2H5p1x_O6_XbpRYswvm_4s_zdsQ==)\n\nKirby McInerney LLP\n(https://www.globenewswire.com/Tracker?data=HpuFE8BDbUz5zHzVeTW4CdAa9jLUegVpcskCN1vBsratYEQkMe4nP64eyLeJJO3UvryBGxG2EAxxS2w_dvZjIiZMQP2fQo7OtlNKIcn3Vyk=)\nis a New York-based plaintiffs’ law firm concentrating in securities,\nantitrust, whistleblower, and consumer litigation. The firm’s efforts on\nbehalf of shareholders in securities litigation have resulted in recoveries\ntotaling billions of dollars. Additional information about the firm can be\nfound at Kirby McInerney LLP’s website\n(https://www.globenewswire.com/Tracker?data=GD-tzL8TuKb6m6uexf0RFqJ5acqDYKfAQZ8bD1NYDRWjql3RglZSnoR0da1vdAmiadhUgStYmlEU9HlYh-Vd3w==).\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and ethical rules.\n\nContacts\nKirby McInerney LLP        \nLauren Molinaro, Esq.\n212-699-1171\nhttps://www.kmllp.com\nhttps://securitiesleadplaintiff.com/\ninvestigations@kmllp.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/192da1d1-643f-4eee-b850-dde5b9f2b00f)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX8XHPqK","title":"QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations","author":"Globe Newswire","ticker":"QGEN","created":"2026-05-14T23:00:00.123Z","tickers":["QGEN","QIA"],"exchange":"NYSE","article_body":"NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney\nLLP\n(https://www.globenewswire.com/Tracker?data=HpuFE8BDbUz5zHzVeTW4CcH9x9umeHwWneV2jzy7mBcJWyVsPfHPvEExCuwY55bHrPkqt4RN_bad4-99HF2VxQJBLeUNlIMYzOR4b1g7nPI=)\nreminds investors of its investigation on behalf of Qiagen N.V. (“Qiagen”\nor the “Company”) (NYSE:QGEN) investors concerning the Company’s and/or\nmembers of its senior management’s possible violation of the federal\nsecurities laws or other unlawful business practices.\n\n[LEARN MORE ABOUT THE INVESTIGATION\n(https://www.globenewswire.com/Tracker?data=nJoh9sk07MJCBCfBtRnd3smwFo2iTg1_nMWy4D03z-E0qrGkJtbvDzIvpMVSHuneKVcZbyiULA3yXoyDjgvsfXFzRzacsn0oTjayTkPilBkWw0FIG84Miamtmjm-lRtmsSeyMwKmCC-FZRzEbk_zUopC737dnNzgdHNKKXaRlbA=)]\n\nWhat Happened?\n\nOn February 5, 2026, Qiagen released fourth quarter 2025 earnings and stated\nthat QuantiFERON would accelerate to achieve “between 6% and 7% growth” in\n2026.\n\nOn April 27, 2026, Qiagen announced preliminary results for the first quarter\nof 2026. Among other things, the Company disclosed that net sales declined\napproximately 1% on a constant exchange rate (“CER”) basis, and that sales\nof its QuantiFERON product declined approximately 5% CER. On this news, the\nprice of Qiagen shares declined by $4.07 per share, or approximately 11%, from\n$38.09 per share on April 27, 2026 to close at $34.02 on April 28, 2026.\n\nWhat Should I Do?\n\nAt this stage, no lawsuit has been filed. The investigation is ongoing to\ndetermine whether claims may be brought under federal securities laws.\n\nIf you purchased or otherwise acquired Qiagen securities, have information, or\nwould like to learn more about this investigation, please contact Lauren\nMolinaro\n(https://www.globenewswire.com/Tracker?data=RlDYPtLpel5m6m8EFtiv4BxO8wlQaSE2m_qHJAip4sVhbDSMWEzDYzPlndLxA9ULnLrlW-qF-0lC0E2ctcaElR0uNyThKAR28tX4t0syC7piWxo6mTCYNZvgo33Ilv5T)\nof Kirby McInerney LLP\n(https://www.globenewswire.com/Tracker?data=HpuFE8BDbUz5zHzVeTW4CZQlsOj4vEjSKg5Q9GKWnqUn7Ea3a3otTxeXJlii64DmO7HQ2YlFyV9ug3n4MZvd9G0GIQ2v3breHmal_Am7Dn0=)\nby email at investigations@kmllp.com, or fill out the contact form below, to\ndiscuss your rights or interests with respect to these matters at no cost.\n\n[LEARN MORE ABOUT SECURITES CLASS ACTIONS]\n(https://www.globenewswire.com/Tracker?data=iloA-mDV8wumtkDot69BfWrtrnRefb3ywsBuuK1QBi0lsTCguaDFCZwdCOS3afPgOTxVuE_KFzIFsFq92y9H0fbzj_opVSHEH1ji2pk0_hkD0UQGo97RHFheFeG2H5p1x_O6_XbpRYswvm_4s_zdsQ==)\n\nKirby McInerney LLP\n(https://www.globenewswire.com/Tracker?data=HpuFE8BDbUz5zHzVeTW4CdAa9jLUegVpcskCN1vBsratYEQkMe4nP64eyLeJJO3UvryBGxG2EAxxS2w_dvZjIiZMQP2fQo7OtlNKIcn3Vyk=)\nis a New York-based plaintiffs’ law firm concentrating in securities,\nantitrust, whistleblower, and consumer litigation. The firm’s efforts on\nbehalf of shareholders in securities litigation have resulted in recoveries\ntotaling billions of dollars. Additional information about the firm can be\nfound at Kirby McInerney LLP’s website\n(https://www.globenewswire.com/Tracker?data=GD-tzL8TuKb6m6uexf0RFqJ5acqDYKfAQZ8bD1NYDRWjql3RglZSnoR0da1vdAmiadhUgStYmlEU9HlYh-Vd3w==).\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and ethical rules.\n\nContacts\nKirby McInerney LLP        \nLauren Molinaro, Esq.\n212-699-1171\nhttps://www.kmllp.com\nhttps://securitiesleadplaintiff.com/\ninvestigations@kmllp.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/192da1d1-643f-4eee-b850-dde5b9f2b00f)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-14T23:00:00.1770308Z","server_sent_at_ms":1778799600177},"received_at":"2026-05-14T23:00:00.278Z","source_url":null},"analysis":{"id":"25333","press_release_id":"35890","analysis_json":{"industry":{"label":"Life Sciences Tools & Services","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Kirby McInerney LLP issued a shareholder-solicitation notice naming Qiagen (QGEN); no new disclosure from the company itself.\n\nThe release is a routine investigation reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.","namedEntities":{"people":[{"name":"Lauren Molinaro","role":"Attorney at Kirby McInerney LLP"}],"products":["QuantiFERON"],"companies":[{"name":"Kirby McInerney LLP","relationship":"plaintiff law firm"},{"name":"Qiagen N.V.","ticker":"QGEN","relationship":"target of investigation"}],"dollarAmounts":[{"amount":"$4.07","context":"share price decline per share"},{"amount":"$38.09","context":"share price on April 27, 2026"},{"amount":"$34.02","context":"share price close on April 28, 2026"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Kirby McInerney LLP. No new disclosure from the issuer; no certified class, no settlement. Boilerplate investigation reminder."},"tickerRelevance":{"others":[],"primary":"QGEN"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Kirby McInerney LLP issued a shareholder-solicitation notice naming Qiagen (QGEN); no new disclosure from the company itself.\n\nThe release is a routine investigation reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","key_figures":{},"named_entities":{"people":[{"name":"Lauren Molinaro","role":"Attorney at Kirby McInerney LLP"}],"products":["QuantiFERON"],"companies":[{"name":"Kirby McInerney LLP","relationship":"plaintiff law firm"},{"name":"Qiagen N.V.","ticker":"QGEN","relationship":"target of investigation"}],"dollarAmounts":[{"amount":"$4.07","context":"share price decline per share"},{"amount":"$38.09","context":"share price on April 27, 2026"},{"amount":"$34.02","context":"share price close on April 28, 2026"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-14T23:00:38.724Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":38394,"modelName":"george-droid-qwen-72b"}}